Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffery Liu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|December 13, 2016
Diclofenac systemic bioavailability of a topical 1% diclofenac + 3% menthol combination gel vs. an oral diclofenac tablet in healthy volunteers: a randomized, open-label, crossover study
Sebastian A Moreira, D Jeffery Liu
Drug Research|November 26, 2016
Skin Irritation and Sensitization Potential of Fixed-Dose Combination of Diclofenac 1% and Menthol 3% Topical Gel: Results of Two Phase I Patch StudiesDongzhou Jeffery Liu, Agron Collaku, Jonathan S Dosik
Plos One|April 27, 2010
Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studiesGuy Lahat, Quan-Sheng Zhu, Kai-Lieh Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2010
TRAIL and doxorubicin combination induces proapoptotic and antiangiogenic effects in soft tissue sarcoma in vivoSuizhao Wang, Wenhong Ren, Jeffery Liu, et al.
Molecular Cancer Therapeutics|August 1, 2012
Targeting the PI3K/mTOR axis, alone and in combination with autophagy blockade, for the treatment of malignant peripheral nerve sheath tumorsMarkus P Ghadimi, Gonzalo Lopez, Keila E Torres, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 10, 2010
An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptorsTingsheng Peng, Pingyu Zhang, Jeffery Liu, et al.
Journal of Clinical Medicine|May 11, 2024
Early Cardiac Evaluation, Abnormal Test Results, and Associations with Outcomes in Patients with Acute Brain Injury Admitted to a Neurocritical Care UnitAbhijit V Lele, Jeffery Liu, Thitikan Kunapaisal, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Clinical Pharmacology and Therapeutics|December 13, 2016
Diclofenac systemic bioavailability of a topical 1% diclofenac + 3% menthol combination gel vs. an oral diclofenac tablet in healthy volunteers: a randomized, open-label, crossover study
Sebastian A Moreira, D Jeffery Liu
Drug Research|November 26, 2016
Skin Irritation and Sensitization Potential of Fixed-Dose Combination of Diclofenac 1% and Menthol 3% Topical Gel: Results of Two Phase I Patch StudiesDongzhou Jeffery Liu, Agron Collaku, Jonathan S Dosik
Plos One|April 27, 2010
Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studiesGuy Lahat, Quan-Sheng Zhu, Kai-Lieh Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2010
TRAIL and doxorubicin combination induces proapoptotic and antiangiogenic effects in soft tissue sarcoma in vivoSuizhao Wang, Wenhong Ren, Jeffery Liu, et al.
Molecular Cancer Therapeutics|August 1, 2012
Targeting the PI3K/mTOR axis, alone and in combination with autophagy blockade, for the treatment of malignant peripheral nerve sheath tumorsMarkus P Ghadimi, Gonzalo Lopez, Keila E Torres, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 10, 2010
An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptorsTingsheng Peng, Pingyu Zhang, Jeffery Liu, et al.
Journal of Clinical Medicine|May 11, 2024
Early Cardiac Evaluation, Abnormal Test Results, and Associations with Outcomes in Patients with Acute Brain Injury Admitted to a Neurocritical Care UnitAbhijit V Lele, Jeffery Liu, Thitikan Kunapaisal, et al.
Pageof 1